Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. microbiol ; 47(1): 251-258, Jan.-Mar. 2016. tab, graf
Article Dans Anglais | LILACS | ID: lil-775122

Résumé

Abstract Dengue is a major worldwide public health problem, especially in the tropical and subtropical regions of the world. Primary infection with a single Dengue virus serotype causes a mild, self-limiting febrile illness called dengue fever. However, a subset of patients who experience secondary infection with a different serotype can progress to a more severe form of the disease, called dengue hemorrhagic fever. The four Dengue virus serotypes (1–4) are antigenically and genetically distinct and each serotype is composed of multiple genotypes. In this study we isolated one Dengue virus 1 serotype, named BR/Alfenas/2012, from a patient with dengue hemorrhagic fever in Alfenas, South Minas Gerais, Brazil and molecular identification was performed based on the analysis of NS5 gene. Swiss mice were infected with this isolate to verify its potential to induce histopathological alterations characteristic of dengue. Liver histopathological analysis of infected animals showed the presence of inflammatory infiltrates, hepatic steatosis, as well as edema, hemorrhage and necrosis focal points. Phylogenetic and evolutionary analyses based on the envelope gene provided evidence that the isolate BR/Alfenas/2012 belongs to genotype V, lineage I and it is probably derived from isolates of Rio de Janeiro, Brazil. The isolate BR/Alfenas/2012 showed two unique amino acids substitutions (SER222THRE and PHE306SER) when compared to other Brazilian isolates from the same genotype/lineage. Molecular models were generated for the envelope protein indicating that the amino acid alteration PHE 306 SER could contribute to a different folding in this region located within the domain III. Further genetic and animal model studies using BR/Alfenas/2012 and other isolates belonging to the same lineage/genotype could help determine the relation of these genetic alterations and dengue hemorrhagic fever in a susceptible population.


Sujets)
Animaux , Humains , Souris , Virus de la dengue/classification , Virus de la dengue/génétique , Dengue/virologie , Variation génétique , Génotype , Phylogenèse , Substitution d'acide aminé , Structures anatomiques de l'animal/anatomopathologie , Brésil , Modèles animaux de maladie humaine , Virus de la dengue/isolement et purification , Produits du gène env/composition chimique , Produits du gène env/génétique , Histocytochimie , Microscopie , Modèles moléculaires , Mutation ponctuelle , Conformation des protéines , Protéines virales non structurales/génétique
2.
Rev. Soc. Bras. Med. Trop ; 40(3): 277-281, maio-jun. 2007. ilus
Article Dans Portugais | LILACS | ID: lil-456319

Résumé

O HTLV-1 é o vírus causador da leucemia/linfoma de célula T no adulto e de uma desordem neurológica conhecida por mielopatia associada ao HTLV ou paraparesia espástica tropical. Um dos modos de transmissão é pelo sangue contaminado e seus subprodutos e, devido ao risco de infecções associadas ao HTLV sua pesquisa na triagem de doadores de sangue foi introduzida no Brasil a partir de 1993. Os kits diagnósticos utilizados nos bancos de sangue nacionais são na sua maioria comprados de empresas estrangeiras. O Brasil não detém a tecnologia para produção deste material e há a necessidade de produção de sistemas de diagnóstico com tecnologia nacional. Neste trabalho, mostramos a expressão da gp21/HTLV-1 em Escherichia coli e sua reatividade frente a anticorpos monoclonais e de pacientes infectados. Expressar tais proteínas é o primeiro passo para obtenção de conjuntos diagnósticos com tecnologia brasileira.


HTLV-1 is the virus that causes T cell lymphoma/leukemia in adults and a neurological disorder known as HTLV-associated myelopathy or tropical spastic paraparesis. One of the transmission means is through contaminated blood and its byproducts. Because of the risk of HTLV-associated infections, screening for HTLV was introduced for Brazilian blood donors in 1993. Most of the diagnostic kits used in the national blood banks are bought from foreign companies. Brazil does not have the technology to produce this material and there is a need to produce diagnostic systems with national technology. In this study, we show the expression of gp21/HTLV-1 in Escherichia coli and its reactivity towards monoclonal antibodies and the antibodies of infected patients. Expressing these proteins is the first step towards obtaining diagnostic kits with Brazilian biotechnology.


Sujets)
Humains , Clonage moléculaire , Produits du gène env/composition chimique , Virus T-lymphotrope humain de type 1/composition chimique , Protéines oncogènes des retroviridae/génétique , Anticorps monoclonaux/génétique , Anticorps monoclonaux/immunologie , Escherichia coli/génétique , Escherichia coli/métabolisme , Expression des gènes , Vecteurs génétiques , Produits du gène env/génétique , Produits du gène env/immunologie , Anticorps anti-HTLVI/génétique , Anticorps anti-HTLVI/immunologie , Virus T-lymphotrope humain de type 1/génétique , Virus T-lymphotrope humain de type 1/immunologie , Immunotransfert , Réaction de polymérisation en chaîne , Protéines oncogènes des retroviridae/isolement et purification
SÉLECTION CITATIONS
Détails de la recherche